Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.

Abstract

AIM Dimethylsulfoxide (DMSO) is the most frequently used agent for hematopoietic cell (HC) graft cryopreservation. This study aimed to monitor blood pressure and heart rate (HR) during HC graft infusion and assess the impact of cryopreservation with DMSO. METHODS 153 HC graft infusions in 153 consecutive hematological patients (mean age 49.1 -/+ 12.6… (More)

Topics

Cite this paper

@article{Horek2009CardiovascularCA, title={Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.}, author={Jakub Hor{\'a}{\vc}ek and Ladislav Jebav{\'y} and Martina Jakl and Pavel Zak and Pavel Měři{\vc}ka and Jan Maly}, journal={Experimental oncology}, year={2009}, volume={31 2}, pages={121-2} }